| Home  | About ScienceAsia  | Publication charge  | Advertise with us  | Subscription for printed version  | Contact us  
Editorial Board
Journal Policy
Instructions for Authors
Online submission
Author Login
Reviewer Login
Volume 49 Number 4
Volume 49 Number 3
Volume 49 Number 2
Volume 49 Number 1
Volume 48 Number 6
Volume 48 Number 5
Earlier issues
Volume 48 Number 5 Volume 48 Number 6 Volume 49 Number 1

previous article next article

Research articles

ScienceAsia 48 (2022): 711-717 |doi: 10.2306/scienceasia1513-1874.2022.100

MYT1L promotes the migration and invasion of glioma cells through activation of Notch signaling pathway

Qiongying Zhanga,†, Ruichun Bib,†, Xiaodong Baob, Xiaohui Xub, Daoquan Fangb, Lei Jiangb,*

ABSTRACT:     MYT1L gene has been associated with various brain diseases as it affects many neuronal and biological processes of nerve cells. However, the role of MYT1L in glioma cell migration and invasion and its mechanism of action are still unclear. In this study, MYT1L was successfully silenced in U87 and A172 cells, and overexpressed in U251 cells using lentiviral vectors. The expression levels of MYT1L in glioma cells were assessed by real-time PCR and Western blot analysis. The effect of MYT1L on migration and invasion was examined by a Transwell assay. We found that MYT1L enhanced cell migration and invasion whereas knockdown of MYT1L suppressed migration and invasion in glioma cells. We also demonstrated that MYT1L activated the Notch signaling pathway, and that treatment with the Notch inhibitor DAPT inhibited the migration and invasion of glioma cells. These results suggest that MYT1L may be considered a useful and potential target in the treatment of glioma.

Download PDF

91 Downloads 784 Views

a Department of Pathology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000 China
b Central Laboratory, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000 China

* Corresponding author, E-mail: jiangleistone79@163.com

Received 14 Sep 2021, Accepted 15 May 2022